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TO:  Managed Care Organizations, Accountable Care Partnership Plans, and 
MassHealth’s Behavioral Health Vendor  
 
FROM: Amanda Cassel Kraft, Acting Medicaid Director   
 
RE:   Updates Regarding Coverage of Medications for Addiction 
Treatment in the Opioid Treatment Programs 
 
 
Background 
 
Managed Care Organizations (MCOs), Accountable Care Partnership Plans (ACPPs), and 
MassHealth’s behavioral health vendor are required to cover opioid treatment services for 
enrolled MassHealth members. (See Appendix C of the MCO and ACPP contracts and 
Appendix A of the behavioral health vendor’s contract.)  
Opioid treatment programs (OTPs) are outpatient programs that deliver opioid treatment 
services by providing monitored administering and dispensing of FDA-approved 
medications for the treatment of opioid use disorder, as well as counseling services. Unlike 
other providers of medications for addiction treatment (MAT), OTPs do not prescribe 
medications, but administer and dispense such medications within the structure of the 
program. Historically, OTPs provided only methadone and counseling services and were 
unable to administer and dispense buprenorphine and naltrexone. OTPs are now 
increasingly able to administer and dispense all FDA-approved MAT, including methadone, 
buprenorphine, and naltrexone. 
As part of the opioid treatment services covered by the plan, MCOs, ACPPs, and the 
behavioral health vendor must cover the administering and dispensing of all FDA-approved 
MAT, including methadone, buprenorphine, and naltrexone, when provided by OTPs in 
their networks or the networks of their behavioral health subcontractor, if applicable. 
All contractual requirements remain in effect except as otherwise stated below.  EOHHS 
intends to update the MCO, ACPP, and behavioral health vendor’s contracts to reflect these 
changes. 
Updates Regarding Coverage of Administering and Dispensing of 
Buprenorphine through OTPs 
 
Effective June 1, 2020, MCOs, ACPPs, and the behavioral health vendor must pay OTPs for 
the preparation and administration of buprenorphine doses, using code H0047, for each 
day that the OTP provides a dose of medication for a member.  MCOs, ACPPs, and the 
behavioral health vendor must also pay, using code H0047, for medications prepared and 
provided by the OTP as take-home doses allowable based on state and federal regulations. 
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Also effective June 1, 2020, MCOs, ACPPs, and the behavioral health vendor should no 
longer pay claims submitted using J0575 and J0574. Rather, MCOs, ACPPS, and the 
behavioral health vendor must accept claims from OTPs using combinations of J0573 and 
J0572 that equal the clinically appropriate dose for the member. Specifically, MCOs, ACPPs, 
and the behavioral health vendor should allow OTPs to use J0573 (for doses greater than 
3mg, but less than or equal to 6mg) to approach the appropriate dose in multiples of 3.1-
6mg and then, when necessary, a single unit of J0572 (for doses less than or equal to 3mg) 
to achieve the exact dose (e.g., 24 mg dose = 4 units J0573, 22mg = 4 units J0573, 20 mg 
dose = 3 units J0573 and 1 unit J0572).  
 
MCOs, ACPPS, and the behavioral health vendor are required to use the following rates and 
billing codes. MassHealth intends to amend the MCO/ACPP contract Appendix T and the 
behavioral health vendor contract Appendix L to reflect these changes. 
 
 
Procedure 
Code  Procedure Description   Unit Cost  
H0047 
Alcohol and/or other drug abuse services, not otherwise 
specified; oral medication preparation and 
administration (buprenorphine and associated drug 
screens); may not be combined with H0033; may be 
billed once per each day a member receives medication 
 $         10.36  
J0572 Buprenorphine/naloxone, oral, less than or equal to 3 mg (maximum of one unit per day; may be combined 
with J0573 as medically necessary) 
 $           4.34  
J0573 
Buprenorphine/naloxone, oral, greater than 3 mg, but 
less than or equal to 6 mg; (may be billed in sufficient 
increments to achieve appropriate dose, may be 
combined with one unit of J0572 as medically 
necessary) 
 $           7.76  
 
 
MassHealth Website 
 
This bulletin is available on the MassHealth website at www.mass.gov/masshealth-provider-
bulletins. 
To sign up to receive email alerts when MassHealth issues new bulletins and transmittal letters, 
send a blank email to join-masshealth-provider-pubs@listserv.state.ma.us. No text in the body or 
subject line is needed. 
 
Questions 
 
If you have any questions about the information in this bulletin, please contact the 
MassHealth Customer Service Center at (800) 841-2900, email your inquiry to 
providersupport@mahealth.net, or fax your inquiry to (617) 988-8974. 
 
